90 related articles for article (PubMed ID: 19174520)
1. Chromosomal location targets different MYC family gene members for oncogenic translocations.
Gostissa M; Ranganath S; Bianco JM; Alt FW
Proc Natl Acad Sci U S A; 2009 Feb; 106(7):2265-70. PubMed ID: 19174520
[TBL] [Abstract][Full Text] [Related]
2. FOXM1 allows human keratinocytes to bypass the oncogene-induced differentiation checkpoint in response to gain of MYC or loss of p53.
Molinuevo R; Freije A; de Pedro I; Stoll SW; Elder JT; Gandarillas A
Oncogene; 2017 Feb; 36(7):956-965. PubMed ID: 27452522
[TBL] [Abstract][Full Text] [Related]
3. MYC's Fine Line Between B Cell Development and Malignancy.
de Barrios O; Meler A; Parra M
Cells; 2020 Feb; 9(2):. PubMed ID: 32102485
[TBL] [Abstract][Full Text] [Related]
4. A germline point mutation in the MYC-FBW7 phosphodegron initiates hematopoietic malignancies.
Freie B; Carroll PA; Varnum-Finney BJ; Ramsey EL; Ramani V; Bernstein I; Eisenman RN
Genes Dev; 2024 Apr; 38(5-6):253-272. PubMed ID: 38565249
[TBL] [Abstract][Full Text] [Related]
5. S146L in MYC is a context-dependent activating substitution in cancer development.
Hinds JW; Feris EJ; Wilkins OM; Deary LT; Wang X; Cole MD
PLoS One; 2022; 17(8):e0272771. PubMed ID: 36018850
[TBL] [Abstract][Full Text] [Related]
6. Isoform-Directed Control of c-Myc Functions: Understanding the Balance from Proliferation to Growth Arrest.
Kubickova A; De Sanctis JB; Hajduch M
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139353
[TBL] [Abstract][Full Text] [Related]
7. A Germline Point Mutation in the MYC-FBW7 Phosphodegron Initiates Hematopoietic Malignancies.
Freie B; Carroll PA; Varnum-Finney BJ; Ramani V; Bernstein I; Eisenman RN
bioRxiv; 2023 Oct; ():. PubMed ID: 37961183
[TBL] [Abstract][Full Text] [Related]
8. Factors That Affect the Formation of Chromosomal Translocations in Cells.
Canoy RJ; Shmakova A; Karpukhina A; Shepelev M; Germini D; Vassetzky Y
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291894
[TBL] [Abstract][Full Text] [Related]
9. MYC Rules: Leading Glutamine Metabolism toward a Distinct Cancer Cell Phenotype.
Tambay V; Raymond VA; Bilodeau M
Cancers (Basel); 2021 Sep; 13(17):. PubMed ID: 34503295
[TBL] [Abstract][Full Text] [Related]
10. Potential role of the OVOL1-OVOL2 axis and c-Myc in the progression of cutaneous squamous cell carcinoma.
Ito T; Tsuji G; Ohno F; Nakahara T; Uchi H; Furue M
Mod Pathol; 2017 Jul; 30(7):919-927. PubMed ID: 28339425
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of programmed DNA lesions and genomic instability in the immune system.
Alt FW; Zhang Y; Meng FL; Guo C; Schwer B
Cell; 2013 Jan; 152(3):417-29. PubMed ID: 23374339
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic Myc translocations are independent of chromosomal location and orientation of the immunoglobulin heavy chain locus.
Spehalski E; Kovalchuk AL; Collins JT; Liang G; Dubois W; Morse HC; Ferguson DO; Casellas R; Dunnick WA
Proc Natl Acad Sci U S A; 2012 Aug; 109(34):13728-32. PubMed ID: 22869734
[TBL] [Abstract][Full Text] [Related]
13. AID-targeting and hypermutation of non-immunoglobulin genes does not correlate with proximity to immunoglobulin genes in germinal center B cells.
Gramlich HS; Reisbig T; Schatz DG
PLoS One; 2012; 7(6):e39601. PubMed ID: 22768095
[TBL] [Abstract][Full Text] [Related]
14. Spatial organization of the mouse genome and its role in recurrent chromosomal translocations.
Zhang Y; McCord RP; Ho YJ; Lajoie BR; Hildebrand DG; Simon AC; Becker MS; Alt FW; Dekker J
Cell; 2012 Mar; 148(5):908-21. PubMed ID: 22341456
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide translocation sequencing reveals mechanisms of chromosome breaks and rearrangements in B cells.
Chiarle R; Zhang Y; Frock RL; Lewis SM; Molinie B; Ho YJ; Myers DR; Choi VW; Compagno M; Malkin DJ; Neuberg D; Monti S; Giallourakis CC; Gostissa M; Alt FW
Cell; 2011 Sep; 147(1):107-19. PubMed ID: 21962511
[TBL] [Abstract][Full Text] [Related]
16. Conditional deletion of N-Myc disrupts neurosensory and non-sensory development of the ear.
Kopecky B; Santi P; Johnson S; Schmitz H; Fritzsch B
Dev Dyn; 2011 Jun; 240(6):1373-90. PubMed ID: 21448975
[TBL] [Abstract][Full Text] [Related]
17. The role of mechanistic factors in promoting chromosomal translocations found in lymphoid and other cancers.
Zhang Y; Gostissa M; Hildebrand DG; Becker MS; Boboila C; Chiarle R; Lewis S; Alt FW
Adv Immunol; 2010; 106():93-133. PubMed ID: 20728025
[TBL] [Abstract][Full Text] [Related]
18. Genetic reporter system for oncogenic Igh-Myc translocations in mice.
Takizawa M; Kim JS; Tessarollo L; McNeil N; Waldschmidt TJ; Casellas R; Ried T; Janz S
Oncogene; 2010 Jul; 29(28):4113-20. PubMed ID: 20453890
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of chromosomal rearrangement in the human genome.
Tsai AG; Lieber MR
BMC Genomics; 2010 Feb; 11 Suppl 1(Suppl 1):S1. PubMed ID: 20158866
[TBL] [Abstract][Full Text] [Related]
20. Aberrantly resolved RAG-mediated DNA breaks in Atm-deficient lymphocytes target chromosomal breakpoints in cis.
Mahowald GK; Baron JM; Mahowald MA; Kulkarni S; Bredemeyer AL; Bassing CH; Sleckman BP
Proc Natl Acad Sci U S A; 2009 Oct; 106(43):18339-44. PubMed ID: 19820166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
